BENEDICTO RAMOS: Open Payments
NPI 1114578556 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,652 in 60 payments from 19 companies in 2025. Trend: 2023 $826 · 2024 $2,869 · 2025 $1,652
Food & beverage: $1,652
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $351 |
| AstraZeneca Pharmaceuticals LP | 9 | $237 |
| ABBVIE INC. | 7 | $220 |
| Madrigal Pharmaceuticals | 1 | $137 |
| PFIZER INC. | 5 | $116 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $104 |
| Exact Sciences Corporation | 5 | $90 |
| Lilly USA, LLC | 3 | $61 |
| Amgen Inc. | 3 | $59 |
| Merck Sharp & Dohme LLC | 3 | $50 |
Products named: Ozempic, VRAYLAR, Rybelsus, BREZTRI, REZDIFFRA, XIFAXAN, The Cologuard Plus Collection Kit, JARDIANCE.
Industry payments across MD — which companies pay providers there.
